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Abstract
Background: Dimerization has emerged as an important feature of chemokine G-protein-coupled receptors. CXCR4 and
CCR5 regulate leukocyte chemotaxis and also serve as a co-receptor for HIV entry. Both receptors are recruited to the
immunological synapse during T-cell activation. However, it is not clear whether they form heterodimers and whether
ligand binding modulates the dimer formation.
Methodology/Principal Findings: Using a sensitive Fluorescence Resonance Energy Transfer (FRET) imaging method, we
investigated the formation of CCR5 and CXCR4 heterodimers on the plasma membrane of live cells. We found that CCR5
and CXCR4 exist as constitutive heterodimers and ligands of CCR5 and CXCR4 promote different conformational changes
within these preexisting heterodimers. Ligands of CCR5, in contrast to a ligand of CXCR4, induced a clear increase in FRET
efficiency, indicating that selective ligands promote and stabilize a distinct conformation of the heterodimers. We also
found that mutations at C-terminus of CCR5 reduced its ability to form heterodimers with CXCR4. In addition, ligands induce
different conformational transitions of heterodimers of CXCR4 and CCR5 or CCR5
STA and CCR5
D4.
Conclusions/Significance: Taken together, our data suggest a model in which CXCR4 and CCR5 spontaneously form
heterodimers and ligand-binding to CXCR4 or CCR5 causes different conformational changes affecting heterodimerization,
indicating the complexity of regulation of dimerization/function of these chemokine receptors by ligand binding.
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Introduction
Chemokine receptors are members of the superfamily of G-
protein-coupled receptors (GPCRs), which posse seven transmem-
brane domains that are interconnected by multiple extracellular
and intracellular loops, and an intracellular C-terminal tail [1].
Chemokines are a large family of small proteins that mediate
recruitment of leukocytes to sites of inflammation and coordinate
their trafficking throughout the human body [2,3]. Gradients of
chemokines that are detected by their receptors control cell traffic
in homeostasis and inflammation in vivo [3]. Chemokines regulate
leukocyte function by binding to specific chemokine receptors
expressed on their surface, typically leading to the activation of
receptor-associated Janus tyrosine kinases (JAKs) and the hetero-
trimeric G-protein GaiGbc [4–7]. One basic question is how
different chemokine receptors receive and transduce signals from
the surface of a cell on which multiple GPCRs are expressed.
Initially, GPCRs were believed to signal as simple monomers
[8,9]. However, mounting evidence now indicates that many
GPCRs, including several chemokine receptors, function as dimers
or higher-order oligomers [8,9].
CXCR4 and CCR5 receptors regulate leukocyte chemotaxis in
inflammation and also serve in conjunction with CD4 as co-
receptors for HIV entry [1,3]. CXCR4 normally functions as the
receptor for the chemokine CXCL12/SDF-1, whereas CCR5
mediates responses to several chemokines, including CCL3/
MIP1-a, CCL4/MIP1-b and CCL5/RANTES [2]. CXCR4
and CCR5 are co-expressed in several leukocyte populations
including lymphocyte and monocytes [3,10]. In addition to their
roles in regulating leukocyte chemotaxis, CXCR4 and CCR5
serve as the entry co-receptors for T-tropic or M-tropic strains of
HIV virus, respectively. Upon the binding of envelope protein
gp120, CD4 receptor physically associates with either CXCR4 or
CCR5 receptors to initiate the formation of the HIV entry
complex [11,12]. CXCR4 or CCR5 can also form heterodimers
with other GPCR receptors for initiation or alteration of signaling
by these involved receptors. For example, CXCR4 and the d-
opioid receptor (DOR), both of which are expressed on the surface
of monocytes and other immune cells, form heterodimers the
presence of ligands for each receptor. The formation of the
CXCR4:DOR heterodimer prevents each of them from signaling
[6]. CCR5 and CCR2 can form heterodimers on the surface of the
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of CCR5 and CCR2, respectively) [5]. The CCR5:CCR2
heterodimers activate heterotrimeric G-protein Gq/11, instead
of Gi, which is activated by CCR5 or CCR2 alone [5]. It appears
that heterodimerization in response to chemokine binding is
required for the termination or alteration of signaling by an
increasing number of chemokine receptors [13].
CXCR4 and CCR5 are expressed on the surface of T
lymphocytes and, during T cell activation, are both recruited to
the immunological synapse (IS). This recruitment requires
chemokine secretion by antigen-presenting cells (APCs) [14].
Therefore, it has been proposed that APC-derived chemokines
promote formation of CXCR4:CCR5 heterodimers, resulting in
accumulation of these receptors at the IS. Despite the important
roles of CXCR4 and CCR5 in chemotaxis, HIV entry, and T cell
activation, it is still not clear whether CXCR4 and CCR5 form
heterodimers on the surface of live cells.
In this report, we investigated the formation of heterodimers
between CXCR4 and CCR5 on the surface of live cells using
FRET imaging coupled with quantitative microscopic analyses.
CXCR4 was tagged with CFP (FRET donor), and CCR5 and two
CCR5 mutants with altered C-termini, CCR5
STA and CCR5
D4,
were fused with YFP (FRET acceptor). We observed that
CXCR4CFP, CCR5YFP, CCR5
STAYFP and CCR5
D4YFP could
be expressed on the surface of live cells. When co-expressed,
CXCR4CFP and CCR5YFP displayed a high level of FRET
signal, indicating that CXCR4 and CCR5 formed heterodimers.
In contrast, CXCR4CFP and CCR5
STAYFP showed a low level of
FRET signal and CXCR4CFP and CCR5
D4YFP showed little
FRET signal, suggesting that mutations in the C-terminus of
CCR5 caused a decrease in CCR5’s ability to form dimers with
CXCR4. Furthermore, CCR5 chemokines, CCL3/MIP1a or
CCL5/RANTES, induced a clear increase, while CXCR4 ligand,
CXCL12/SDF-1, triggered a decrease in FRET between
CXCR4CFP and CCR5YFP, suggesting that the binding of these
chemokines differentially modulates the stability or conformation
of CXCR4:CCR5 heterodimers in the plasma membrane.
Materials and Methods
Chemicals and reagents
pEYFP-N1 and pECFP-N1 were purchased from Clontech
(Palo Alto, CA). Lipofectamine 2000 was purchased from
Invitrogen (Grand Island, NY). CCL3/MIP1a, CCL5/RANTES
and CXCL12/SDF1a were purchased from BioSource (Camar-
illo, CA). Fluo-4-AM was from Molecular Probes (Eugene, OR).
Anti-GFP monoclonal antibody (JL-8) was from BD Biosciences
Clontech (Palo Alto, CA). All of the other reagents were of reagent
grade and were obtained from standard suppliers.
Plasmid, cell line, and transfection
Human CXCR4 and CCR5 gene were generated by PCR.
Plasmids carrying mutant receptors CCR5
STA and CCR5
D4 were
generous gifts from Dr. Murphy’s group at NIAID, NIH. The
plasmids encoding CCR5YFP, CCR5
STAYFP and CCR5
D4YFP
were constructed by inserting the PCR product of CCR5,
CCR5
STA and CCR5
D4 into the pEYFP-N1 vectors in multicloning
sites. The plasmid encoding CXCR4CFP was constructed by
inserting the PCR product of CXCR4 into the pECFP-N1 vector.
HEK293T cells were cultured in Dulbecco modified Eagle medium
supplemented with fetal calf serum (10%), penicillin (5 mg/ml), and
streptomycin (5 mg/ml) and were grown in 5% CO2 at 37uC.
HEK293T cellswere transfectedorco-transfectedwiththe plasmids
encoding CCR5YFP, CCR5
STAYFP, CCR5
D4YFP and/or
CXCR4CFP mediated by Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s instructions [16].
Calcium assay
HEK293T cells were seeded in four-well chambers at 10
4/ml,
24–36 hrs before the experiments. After 3 hours of starvation, the
cells were labeled by incubation with Fluo-4-AM in Hanks
balanced salt solution for half an hour, washed twice, and
incubated for half an hour before being taken images under the
microscope. Upon the addition of SDF-1 (50 nM) or RANTES
(50 nM) to the cell chamber, time-lapse images were collected with
multi-track mode (Zeiss 510), and CFP and Fluo-4 images were
digitally separated. Changes in Ca
2+ concentration were repre-
sented as the changes in the intensity of Fluo-4 (It/I0, where It is
the intensity at time t, and I0 is the intensity at time 0) as previous
described [7].
Imaging and FRET assay
Cells were washed twice with 16HBSS and then starved in
16HBSS+1%BSA for 3 hrs. Before imaging, the cells were treated
with chemokines for 20 min. Zeiss Plan-apochromat 406 oil
immersion objective was used for image acquisition. Images were
collected with multi-track mode (Zeiss 510). In Track I, there were
two channels, cells were excited with 458 nm, CFP emission
signals were collected through Channel I (475–525 nm) and
FRET emission signals were collected through Channel II
(.530 nm). In Track II, there was only one YFP channel, YFP
emission signals were collected with this channel (.530 nm).
FRET efficiency between CFP and YFP was analyzed using Zeiss
LSM Software.
Intermolecular FRET efficiency was shown as N-FRET using
macro of Zeiss LSM Software. Briefly, Sensitized Emission bleed-
through (or crosstalk) coefficients were determined using control
cells that expressed only CFP or YFP and expressed as correction
factors as follows. Donor coefficients Fd/Dd: the amount of
crosstalk of donor signal into the FRET channel. Ad/Fd: the
amount of crosstalk of FRET signal into the Acceptor channel.
Acceptor coefficients: Fa/Aa: the amount of crosstalk of the
acceptor signal into the FRET channel. Da/Fa: the amount of
crosstalk of the acceptor signal into the donor channel. Da/Fa: the
amount of crosstalk of the FRET signal into the donor channel.
Display N-FRET image with intensities that is converted from the
FRET index is calculated for each pixel by LSM FRET tool for
Carl Zeiss AIM software using the method Xia and Liu [17]. For
quantification of N-FRET, regions of interest (ROIs) covering the
plasma membrane from the acquired images were chosen,
processed as above, and calculated automatically using the FRET
macro of LSM imaging software as previously described [16].
Means and SD are shown. Statistical significance was determined
with Student’s t-test.
Results
Expression of CXCR4, CCR5, and mutant CCR5 receptors
tagged with fluorescent proteins
To investigate the distributions of CXCR4 and CCR5 in the
plasma membrane of live cells, we fused CFP to the C-terminus of
CXCR4, and YFP to the C-terminus of CCR5. It is well known
that upon activation of CCR5 the C-terminal tail interacts with
GPCR kinase(s) and arrestin to carry out receptor functions [9]. In
this study, we selected two CCR5 mutants, CCR5
STA and
CCR5
D4, and fused YFP to their C-termini. CCR5
STA is a
CCR5 mutant in which all serines and threonines in the C-
terminal tail were replaced by alanines; while CCR5
D4 is a mutant
Dimerization of CXCR4 and CCR5
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were removed [15]. HEK293 cells were transfected with the
CXCR4CFP, CCR5YFP, CCR5
D4YFP or CCR5
STAYFP con-
structs and expression of appropriately sized fusion proteins was
verified by western blotting with anti-GFP antibodies (Figure 1A).
Fluorescence microscopy revealed that the majority of
CXCR4CFP, CCR5YFP, CCR5
STAYFP was expressed uniformly
on the plasma membrane (Figure. 1B). The surface expression of
CCR5
D4YFP, on the other hand, was less efficient compared to
the other tagged receptors. Consistent with a previous report [15],
CCR5
D4YFP was frequently localized to the interior of transfected
cells (data not shown). However, it was expressed on the cell
surface in a small fraction of the cells under our experimental
condition, which allowed us to carry out the measurement of
CCR5
D4YFP on the surface of live cells (Figure 1B).
Functional characterization of the tagged receptors
To test the functionality of CXCR4CFP, we examined ligand-
induced Ca
2+ responses in the cells that expressed CXCR4CFP on
the cell surface (Figure 2A). We imaged fluorescence intensity
change of Fluo-4, a calcium indicator, triggered by the CXCR4
ligand SDF-1. Using a confocal fluorescence microscope (Zeiss 510
META), fluorescence images of CXCR4CFP and Fluo-4 were
simultaneously recorded in a time-lapse experiment (Figure 2A).
CXCR4CFP primarily localized to the cell surface, while Fluo-4
was distributed throughout the cytosol. Upon addition of SDF-1 to
the cell chamber, the Fluo-4 fluorescence signal transiently
increased in the cytosol of the CXCR4CFP cells but not that of
the parental HEK293 cells, indicating that the CXCL12/SDF-1-
elicited Ca
2+ response was specifically mediated by the expressed
CXCR4CFP (Figure 2A and 2B). Our previous study demon-
strated that the CCR5 receptor fused with CFP at its C-terminus is
also functional in the ligand-induced Ca
2+ response [16]. We also
investigated ligand-induced Ca
2+ response in cells expressing
CCR5
STAYFP and CCR5
D4YFP under the same live cell imaging
conditions (Figure 2C). Upon addition of MIP1a, a ligand for
CCR5, to the cell chamber, Fluo-4 fluorescence signal increased in
the cells expressing CCR5-YFP, CCR5
STAYFP and CCR5
D4YFP,
indicating that these tagged receptors also retained their ligand-
binding and signaling functions (Figure 2C). However,
CCR5
STAYFP and CCR5
D4YFP triggered the Ca
2+ responses
with different kinetics compared with that induced by CCR5YFP,
indicating that mutations of the C-terminal tail of CCR5 affected
its ability in signaling (Figure 2C). Taken together, cells expressing
CXCR4CFP, CCR5YFP, CCR5
STAYFP and CCR5
D4YFP pro-
vide a system for probing extracellular ligand-induced changes in
Figure 1. Expression of CXCR4 or CCR5 and CCR5 mutant receptors tagged with fluorescent proteins. A. The indicated CFP- or YFP-
tagged receptors, transiently expressed in HEK293 cells, were detected in whole cell lysates by western blotting with an anti-GFP antibody.
Untransfected HEK293 cells were included as a negative control. B. Schematic diagram of CXCR4CFP, CCR5YFP, CCR5
STAYFP and CCR4
D4YFP on the
cell membrane. Confocal images of living cells expressing membrane-localized CXCR4CFP (cyan), CCR5YFP (red), CCR5
STAYFP (red) and CCR5
D4YFP
(red); top panels, fluorescence images. Bottom panels, the merged images of the fluorescence and differential-interference-contrast (DIC) images.
Scale bar, 10 mm.
doi:10.1371/journal.pone.0003424.g001
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of live cells.
Co-localization of CXCR4 and CCR5 or CCR5 mutant
receptors
We investigated membrane distribution of CXCR4 and CCR5
or CCR5 mutants in HEK293 cells that co-expressed
CXCR4CFP and either CCR5YFP, CCR5
STAYFP or
CCR5
D4YFP. Using multitrack and line-scanning mode of a
laser-scanning confocal microscope, cells were simultaneously
recorded in the CFP and YFP detection channel. We observed
that CXCR4CFP co-localized on the cell surface with each of the
CCR5 variants (Figure 3). However, this co-localization does not
prove that the receptors are physically associated given that the
spatial resolution of light microscopy is more than 200 nm.
Therefore, we used the FRET imaging method to determine if
CXCR4CFP was in close proximity to CCR5YFP, CCR5
STAYFP
and CCR5
D4YFP on the cell surface.
CXCR4 and CCR5 exist as preformed dimers on the cell
surface
To examine interactions between CXCR4 and CCR5, we
measured FRET between CFP and YFP in cells co-expressing
CXCR4CFP and CCR5YFP. For this we used confocal
microscopy and the sensitized emission method to calculate FRET
efficiency between the CFP and YFP moieties. Using a multitrack
and line-scanning mode of a laser-scanning confocal microscope,
cells were simultaneously recorded in the CFP and YFP, and
FRET detection channels. Fluorescence was simultaneously
collected pixel-by-pixel from three detection channels: CFP
(458 nm, CFP excitation, 475–525 nm, CFP emission); FRET
(458 nm, CFP excitation; long pass filter 530 nm, YFP emission);
and YFP (514 nm, YFP excitation, long pass filter 530 nm, YFP
emission) (Figure 4A). We first obtained bleed-through (cross talk)
co-efficient by analyzing images from cells expressing only
CXCR4CFP or CCR5YFP, which were imaged with the identical
configuration and scanning setup as the controls (Figure 4B). We
then obtained normalized FRET (N-FRET) efficiency in the
plasma membrane of cells expressing both CXCR4CFP and
CCR5YFP. Using the FRET analysis tool, the FRET macro for
the Ziess LSM 510 META microscope, the normalized FRET (N-
FRET) image with intensities was converted from the FRET index
calculated from each pixel as previously described [16,17] (details
in Materials and Methods).
An advantage of using confocal microscopy to evaluate FRET is
that individual region of interests (ROIs) within a cell can be
selectively examined for FRET efficiency [18]. In contrast,
fluorometric [19] or flow cytometric [20,21] approaches can only
Figure 2. Ligand-induced Ca
2+ response in living cells express-
ing CXCR4CFP, CCR5YFP, CCR5
STAYFP or CCR5
D4YFP. A.
CXCR4CFP mediated a transient intracellular Ca
2+ elevation, which is
visualized as intensity changes of Fluo-4 (rainbow color). SDF-1 was
added at time 0. B. A time course of intracellular Ca
2+ changes
following the addition of SDF-1 at time 0. SDF-1-induced Ca
2+ response
in cells expressing CXCR4CFP (black circles) (n=7) or HEK293 cells as a
control (gray triangles) (n=4). Means6S.D. are shown. C. A time course
of intracellular Ca
2+ changes following the addition of MIP1a, a ligand
of CCR5, at time 0. MIP1a-induced Ca
2+ responses in cells expressing
CCR5 (black circles) (n=4), CCR5
STAYFP (gray squares) (n=6) and
CCR5
D4YFP (gray triangles) (n=10). Means6S.D. are shown.
doi:10.1371/journal.pone.0003424.g002
Figure 3. Co-localization of CXCR4 and CCR5 or CCR5 mutants
on the surface of living cells. HEK293 cells were co-transfected with
CFP-tagged CXCR4 and YFP-tagged CCR5, or CCR5 mutants. Fluores-
cence images show distribution of CXCR4CFP (cyan) and CCR5YFP,
CCR5STAYFP or CCR5D4YFP (red). The merged images are presented to
show co-localization.
doi:10.1371/journal.pone.0003424.g003
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of fluorophores in intracellular compartments. Because we were
interested in CXCR4 and CCR5 interactions at the cell surface,
only the plasma membrane region of the cell was selected as the
ROIs (Figure 3C). FRET efficiency is usually sensitive to the
relative amounts of donors and acceptors in the selected regions.
However, we took the following steps to minimize the possibility
that our measurements were strongly influenced by high levels of
the receptor expression. First, all the FRET images were recorded
using identical parameters, including excitation laser intensity,
detector gains and magnification. Therefore, the levels of
CXCR4CFP and CCR5YFP, CCR5
STAYFP or CCR5
D4YFP
were clearly monitored pixel-by-pixel by CFP and YFP intensities.
Second, in our analyses, we selected regions having mean CFP and
YFP intensities between 600 and 2800 to ensure the proper
receptor levels. Finally, FRET values were normalized pixel-by-
pixel by dividing by the square root of the donor and acceptor
concentrations to yield N-FRET values. We have previously
shown that such N-FRET values are relatively independent of the
CFP or YFP concentrations and, therefore, likely reflect receptor
interactions [16,22].
We used tagged receptors for IL17 and TNF (IL17RA-YFP and
TNFR-CFP), which both localize to the cell membrane and do not
associateasareceptorcomplex,asnegative controlsfordetermining
the baseline for FRET efficiency [20,22]. Strikingly, cells expressing
CXCR4CFP and CCR5YFP showed a marked enhancement of
FRET (Figure 4B and 4D). In clear contrast, cells that expressed
membrane-localized CXCR4CFP and CCR5
D4YFP showed very
low FRET intensity, while cells expressing CXCR4CFP and
CCR5
STAYFP displayed moderate FRET signal (Figure 4B and
4D). Quantitative analyses of FRET efficiency indicated that
normalized FRET (N-FRET) between CXCR4CFP:CCR5YFP
(n=198) was significantly greater than in the case of
CXCR4CFP:CCR5
D4YFP (n=148, p,0.01) or the negative
control (n=58, p,0.01) (Figure 4D). In addition, the intermediate
N-FRET value obtained for CXCR4CFP:CCR5
STAYFP (n=156)
was significantly lower than that of CXCR4CFP:CCR5YFP
(p,0.01) but still higher than those of CXCR4CFP:CCR5
D4YFP
(p,0.01) and the negative control (p,0.01). On the other hand, N-
FRET of CXCR4CFP:CCR5
D4YFP did not significantly differ
from that of the control (p.0.01). Together, these data suggest that
CCR5 dimerizes with CXCR4 on the plasma membrane in the
Figure 4. An analysis of CXCR4 and CCR5 association on the surface of live cells by FRET imaging. A. Schematic diagram of FRET
measurement between CFP-tagged CXCR4 and YFP-tagged CCR5. When cells were excited at 458 nm, emissions are simultaneously recorded in CFP
channel and FRET channel, and when cells were excited at 514 nm, emissions were recorded in YFP channels. We used multi-channel and line-
scanning mode so that images of three channels were recorded simultaneously. Cells expressing only CXCR4CFP or CCR5YFP were used as controls
for calculating real FRET efficiency that is expressed as normalized FRET (N-FRET). B. Images of cells expressing only CXCR4CFP or CCR5YFP;
CXCR4CFP with CCR5YFP, and CCR5
STAYFP or CCR5
D4YFP. N-FRET images show FRET intensities. C. FRET efficiency, N-FRET, in the plasma membrane
was measured in selected regions of interest (ROIs). One example is shown. D. Quantitative analysis of N-FRET on cells expressing CXCR4CFP and
CCR5YFP (n=198), CCR5
STAYFP (n=156) or CCR5
D4YFP (n=148) is shown as means6S.D. Cells expressing IL17RA-YFP and TNFR-CFP (n=58) were
used as negative control. Statistical significance was assessed using a t-test.
doi:10.1371/journal.pone.0003424.g004
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of CCR5
STA or CCR5
D4 reduce or abolish the receptor’s ability to
form pre-existing dimers with CXCR4.
Ligand binding to CCR5 or CXCR4 differentially affects
heterodimers
To examine the effects of CCR5 and CXCR4 ligands on the
pre-existing dimers, we measured the FRET efficiency between
CXCR4CFP and CCR5YFP upon stimulation with CCL3/
MIP1a and CCL5/RANTES (ligands of CCR5) and CXCL12/
SDF-1 (a ligand of CXCR4). Relative to the unstimulated control,
both of the CCR5 ligands induced N-FRET increases between
CXCR4CFP and CCR5YFP of roughly 30% (p,0.01 for both),
while CXCL12/SDF-1 (n=119) triggered a slight decrease in the
N-FRET signal (p,0.01) (Figure 5A and 5B) These results suggest
that ligands binding to each receptor comprising the heterodimer
distinctly alter its conformation. In contrast to the results obtained
with CCR5YFP, addition of CCL3/MIP1a (n=105) resulted in a
decrease in N-FRET (p,0.01) while CCL5/RANTES (n=97) did
not cause a significant change (p.0.05) in N-FRET between
CXCR4CFP and CCR5
STAYFP (n=156 with no stimulation)
(Figure 5). Interestingly, while CCR5
D4YFP could hardly form
dimers with CXCR4CFP (n=148) in the absence of ligands,
addition of CCL3/MIP1a (n=85) and CXCL12/SDF-1 (n=96)
caused clear increases in N-FRET between these receptors
(p,0.01 for both), suggesting that binding of either CXCL12/
SDF-1 to CXCR4 or CCL3/MIP1a (but not CCL5/RANTES
n=138, p.0.05) to CCR5
D4 promotes the formation of
CXCR4:CCR5
D4 heterodimers. Taken together, our results
suggest that the formation of heterodimers between CXCR4
and CCR5 is a dynamic process and that ligand binding may
cause conformational changes in pre-existing CXCR4:CCR5
dimers, destabilize CXCR4:CCR5
STA heterodimers or promote
CXCR4:CCR5
D4 heterodimer formation.
Discussion
In recent years, a number of GPCRs have been shown to exist
as dimers in the plasma membrane, raising a number of interesting
questions regarding the molecular dynamics and functional
significance of receptor dimer formation [9]. One of the highly
debated questions is whether dimerization in the cell membrane
occurs spontaneously or is induced by ligand binding. The
chemokine receptors CXCR4 and CCR5 regulate leukocyte
chemotaxis and are also instrumental in the entry of HIV into
immune cells [12,23]. However, their dimerization properties have
not been clearly defined. In this study using a fluorescence
resonance energy transfer imaging, we provide the first evidence
that CXCR4 and CCR5 form heterodimers on the plasma
membrane in the absence of chemokines and that their chemokine
ligands induced different conformational changes that either
promote or destabilize the formation of heterodimers.
Our results indicate that CXCR4 and CCR5 heterodimers exist
on the surface of cells in the absense of ligand stimulation and that
point mutations within or deletion of the C-terminus of CCR5
reduce the ability of the receptor to form heterodimers with
CXCR4 (Fig. 3). CCR5 has been previously shown to form
homodimers and heterodimers with CCR2 chemokine receptor
[5]. Previous studies indicated that transmembrane regions TM1,
TM2 and TM4 of CCR5 are involved in the homodimer
formation. Several amino acids, such as Ile52 in TM1 and
Val150 in TM4, have been shown to be crucial for CCR5 function
and homodimerization [24]. The role of the C-terminus of CCR5
has been examined in receptor surface expression, receptor
signaling and HIV entry. The C-terminal deletion mutants
reduced the surface expression [15,25,26]. We found the
CCR5
STA mutant was expressed on the cell surface, and its
chemokine-induced Ca
2+ response prolonged, which is consistent
with the defect of the receptor in desensitization that is required
for phosphorylation at C-terminus [15]. We also found that the
deletion mutant CCR5
D4 was aberrantly expressed in the cytosol
in a majority of transfected cells, but surface expression of
CCR5
D4 was detected in a small number of cells. Using live single
cell imaging, we were able to use these mutants to analyze
functions of the C-terminus in chemokine-induced Ca
2+ responses
and heterodimer formation. Our data suggested that the C-
terminal tail of CCR5 may be involved in the formation of
CXCR4 and CCR5 heterodimers.
Our data revealed that ligand binding to CCR5 or CXCR4
could either promote or destabilize the formation of heterodimers.
Previous studies indicated that ligand binding could promote the
formation of homo- or heterodimers. For example, the CXCR4
and d-opioid receptor (DOR) form both homo- and heterodimers
and extracellular ligands could alter the complexes of these dimers
[6]. DPDPE, a ligand of DOR, induces DOR homodimers;
CXCL12/SDF-1, a ligand of CXCR4, triggers the formation of
CXCR4 homodimers; and DPDPE and SDF-1 together promote
assembly of heterodimeric CXCR4:DOR complexes. It has been
proposed that the formation of homo- or heterodimers on the cell
membrane, where various receptors co-exist, is a dynamic process,
Figure 5. Ligand-binding induced FRET changes between
heterodimers. A. A representative image of a cell expressing
CXCR4CFP and CCR5YFP that was stimulated with RANTES. The N-FRET
image shows marked FRET signals. B. Cells expressing CXCR4CFP and
CCR5YFP, or CCR5
STAYFP or CCR5
D4YFP were stimulated with ligands
such as CCL3/MIP1a, CCL5/RANTES, or CXCL12/SDF-1. Quantitative
analyses of N-FRET under each condition. Data for N-FRET are shown as
means6S.D. Statistically significant N-FRET changes are indicated as p-
values in the results.
doi:10.1371/journal.pone.0003424.g005
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complexes of receptors. Our study indicated a new level of
complexity regarding to the effect of ligand binding on the
formation of receptor heterodimers. While binding of CCL3/
MIP1a and CCL5/RANTES to CCR5 promoted the formation
of CCR5:CXCR4 heterodimers, CXCL12/SDF-1 binding to
CXCR4 reduced the level of preexisting CCR5:CXCR4 hetero-
dimers. Mutations in the C-terminal tail of CCR5 not only
reduced or abolished its ability to form heterodimers with CXCR4
but also altered effects of ligand binding on the formation of
heterodimers with CXCR4. CCL3/MIP1a binding to CCR5
STA
mutant receptor reduced its ability to form heterodimer with
CXCR4, while the binding of CCL5/RANTES to CCR5 or
CXCL12/SDF-1 to CXCR4 had no apparent effect. Further-
more, CCL3/MIP1a and CXCL12/SDF-1 binding to either
CCR5
D4 mutant or CXCR4 promoted formation of heterodimers.
Our results suggest that ligand binding to a chemokine receptor
causes a conformational change in the receptor that can either
promote or destabilize the formation of receptor dimers.
Mutations of the C-terminal domain of a receptor affect ligand-
induced conformational changes, thereby altering its potential to
form dimers.
Our results have clear implication for the in vivo physiology of
chemokine and their receptors. It has been suggested that
chemokines secreted by antigen-presenting cells recruit both
CXCR4 and CCR5 to the immunological synapse (IS) during T
cell activation [14]. Our data suggest that this accumulation of
both CXCR4 and CCR5 could be mediated by chemokine-
promoted formation of CXCR4:CCR5 heterodimers. Our results
also provide information on the functions of the C-terminal tail of
chemokine receptors in dimerization and thus define additional
targets for potential drugs in chemokine-related diseases. It should
be noted that our study was performed using HEK293 cells
expressing CFP- or YFP-tagged receptors. Whether or not the
CXCR4:CCR5 dimerization and ligand-induced changes we
observed occur in actual leukocytes in vivo remains to be
determined. New techniques are to be developed in order to
apply this imaging approach in vivo [27].
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